Prothionamide
产品说明书
 |
同义名 : | 2-丙基吡啶-4-硫代甲酰胺 ;Protionamide;Tebeform;2-Propyl-4-thiocarbamoylpyridine;2-Propyl-4-pyridinecarbothioamide;1321-TH |
| CAS号 : | 14222-60-7 | |
| 货号 : | A306379 | |
| 分子式 : | C9H12N2S | |
| 纯度 : | 98% | |
| 分子量 : | 180.27 | |
| MDL号 : | MFCD00464119 | |
| 存储条件： |
Pure form Inert atmosphere,Store in freezer, under -20°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 105 mg/mL(582.46 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Protionamide is a drug used in the treatment of tuberculosis and has also been tested for use in the treatment of leprosy. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03237182 | Tuberculosis, Multidrug-Resist... 展开 >>ant 收起 << | Phase 4 | Recruiting | December 2021 | South Africa ... 展开 >> King Dinuzulu Hospital Recruiting Durban, Kwa-Zulu Natal, South Africa Contact: Nesri Padayatchi, MBcHB 0312604550 nesri.padayatchi@caprisa.org Contact: Resha Boodhram, BTech 0828383651 resha.boodhram@caprisa.org 收起 << |
| NCT00042289 | HIV Infections | Phase 4 | Recruiting | September 30, 2019 | - |
| NCT00513396 | Tuberculosis, Multidrug-Resist... 展开 >>ant 收起 << | Phase 2 Phase 3 | Completed | - | - |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
5.55mL 1.11mL 0.55mL |
27.74mL 5.55mL 2.77mL |
55.47mL 11.09mL 5.55mL |
| 参考文献 |
|---|